Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

December 09, 2021

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

Evidence gaps: What’s Needed in the New Guidelines?

Presentation TCT 2021

Evidence gaps: What’s Needed in the New Guidelines?

Presenter: David Cohen

November 05, 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Recognizing the Value Proposition of DCB in the Real-World

Presentation TCT 2021

Recognizing the Value Proposition of DCB in the Real-World

Presenter: David Cohen

November 04, 2021

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

News Opinion Conversations in Cardiology

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

October 12, 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

July 26, 2021

TV Trials and Economics: What Is a TV Life Worth?

Presentation TVT 2021

TV Trials and Economics: What Is a TV Life Worth?

Presenter: David Cohen

July 22, 2021

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

Presentation TVT 2021

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

Presenter: David Cohen

July 20, 2021

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

News Conference News EuroPCR 2021

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

May 21, 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

Video

» On Record

Understanding Noninferiority Trials: Purpose, Power, and Pitfalls

September 24, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.